We therefore investigated the marker expression of MLH1, MSH2, MSH6, and PMS2; however, they were all found to be present in both mucinous carcinoma and undifferentiated lesions, indicating the mismatch repair proficiency of this tumor (Figure 6C). This evidence concerns the gene PMS2 and mucinous adenocarcinoma.